Solotek Reports May 2026 Revenue of NT$716 Million, Up 36.7% Year-on-Year
AI Summary (NQ-processed)
Solotek achieved NT$716 million in revenue for May 2026, representing a 36.7% year-on-year increase, highlighting strong momentum in the biotech and healthcare sector.
AI Analysis
Frequently Asked Questions
Q: What was Solotek's revenue in May 2026?
A: Solotek reported NT$716 million in revenue for May 2026, up 36.7% YoY.
Q: What does Solotek do?
A: Solotek is a Taiwanese biotech firm specializing in medical devices and health-tech solutions.
Q: What drove Solotek's growth?
A: Growth was driven by new product launches, rising Asia demand, and B2B/B2C expansion.